Therapeutics: Our partnerships and collaborations

Topelia has established strong partnerships with world-renowned experts who bring specialised knowledge and robust resources. These collaborations will play a crucial role in guiding the development of Topelia's proprietary TPL101 Antiviral Triple Therapy (ATT) for treating coronavirus infections.

Manufacturing
Advisory
Clinical Trials and Regulatory